Global Medical Blood Products Market Analysis and Forecast 2025-2031

Summary

According to APO Research, The global Medical Blood Products market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Medical Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Medical Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Medical Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Medical Blood Products is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Medical Blood Products include Beijing Tiantan Biological Products, China Biologic Products Holdings, RAAS, HUALAN BIOLOGICAL ENGINEERING, China Resources Boya Bio-pharmaceutical Group, Takeda, Octapharma, LFB Group and Kedrion, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Medical Blood Products, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Medical Blood Products, also provides the sales of main regions and countries. Of the upcoming market potential for Medical Blood Products, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Blood Products sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Medical Blood Products market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Medical Blood Products sales, projected growth trends, production technology, application and end-user industry.


Medical Blood Products Segment by Company

Beijing Tiantan Biological Products
China Biologic Products Holdings
RAAS
HUALAN BIOLOGICAL ENGINEERING
China Resources Boya Bio-pharmaceutical Group
Takeda
Octapharma
LFB Group
Kedrion
Grifols
CSL
BPL
Biotest

Medical Blood Products Segment by Type

Protein Products
Coagulation Factor Products
Other Blood Products
Whole Blood And Blood Components
Plasma Products

Medical Blood Products Segment by Application

Hospital
Clinic

Medical Blood Products Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Medical Blood Products in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Medical Blood Products manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Blood Products sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Medical Blood Products Market by Type
1.2.1 Global Medical Blood Products Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Protein Products
1.2.3 Coagulation Factor Products
1.2.4 Other Blood Products
1.2.5 Whole Blood And Blood Components
1.2.6 Plasma Products
1.3 Medical Blood Products Market by Application
1.3.1 Global Medical Blood Products Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Medical Blood Products Market Dynamics
2.1 Medical Blood Products Industry Trends
2.2 Medical Blood Products Industry Drivers
2.3 Medical Blood Products Industry Opportunities and Challenges
2.4 Medical Blood Products Industry Restraints
3 Global Market Growth Prospects
3.1 Global Medical Blood Products Revenue Estimates and Forecasts (2020-2031)
3.2 Global Medical Blood Products Revenue by Region
3.2.1 Global Medical Blood Products Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Medical Blood Products Revenue by Region (2020-2025)
3.2.3 Global Medical Blood Products Revenue by Region (2026-2031)
3.2.4 Global Medical Blood Products Revenue Market Share by Region (2020-2031)
3.3 Global Medical Blood Products Sales Estimates and Forecasts 2020-2031
3.4 Global Medical Blood Products Sales by Region
3.4.1 Global Medical Blood Products Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Medical Blood Products Sales by Region (2020-2025)
3.4.3 Global Medical Blood Products Sales by Region (2026-2031)
3.4.4 Global Medical Blood Products Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Medical Blood Products Revenue by Manufacturers
4.1.1 Global Medical Blood Products Revenue by Manufacturers (2020-2025)
4.1.2 Global Medical Blood Products Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Medical Blood Products Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Medical Blood Products Sales by Manufacturers
4.2.1 Global Medical Blood Products Sales by Manufacturers (2020-2025)
4.2.2 Global Medical Blood Products Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Medical Blood Products Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Medical Blood Products Sales Price by Manufacturers (2020-2025)
4.4 Global Medical Blood Products Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Medical Blood Products Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Medical Blood Products Manufacturers, Product Type & Application
4.7 Global Medical Blood Products Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Medical Blood Products Market CR5 and HHI
4.8.2 2024 Medical Blood Products Tier 1, Tier 2, and Tier 3
5 Medical Blood Products Market by Type
5.1 Global Medical Blood Products Revenue by Type
5.1.1 Global Medical Blood Products Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Medical Blood Products Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Medical Blood Products Revenue Market Share by Type (2020-2031)
5.2 Global Medical Blood Products Sales by Type
5.2.1 Global Medical Blood Products Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Medical Blood Products Sales by Type (2020-2031) & (K Units)
5.2.3 Global Medical Blood Products Sales Market Share by Type (2020-2031)
5.3 Global Medical Blood Products Price by Type
6 Medical Blood Products Market by Application
6.1 Global Medical Blood Products Revenue by Application
6.1.1 Global Medical Blood Products Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Medical Blood Products Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Medical Blood Products Revenue Market Share by Application (2020-2031)
6.2 Global Medical Blood Products Sales by Application
6.2.1 Global Medical Blood Products Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Medical Blood Products Sales by Application (2020-2031) & (K Units)
6.2.3 Global Medical Blood Products Sales Market Share by Application (2020-2031)
6.3 Global Medical Blood Products Price by Application
7 Company Profiles
7.1 Beijing Tiantan Biological Products
7.1.1 Beijing Tiantan Biological Products Comapny Information
7.1.2 Beijing Tiantan Biological Products Business Overview
7.1.3 Beijing Tiantan Biological Products Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Beijing Tiantan Biological Products Medical Blood Products Product Portfolio
7.1.5 Beijing Tiantan Biological Products Recent Developments
7.2 China Biologic Products Holdings
7.2.1 China Biologic Products Holdings Comapny Information
7.2.2 China Biologic Products Holdings Business Overview
7.2.3 China Biologic Products Holdings Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 China Biologic Products Holdings Medical Blood Products Product Portfolio
7.2.5 China Biologic Products Holdings Recent Developments
7.3 RAAS
7.3.1 RAAS Comapny Information
7.3.2 RAAS Business Overview
7.3.3 RAAS Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 RAAS Medical Blood Products Product Portfolio
7.3.5 RAAS Recent Developments
7.4 HUALAN BIOLOGICAL ENGINEERING
7.4.1 HUALAN BIOLOGICAL ENGINEERING Comapny Information
7.4.2 HUALAN BIOLOGICAL ENGINEERING Business Overview
7.4.3 HUALAN BIOLOGICAL ENGINEERING Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 HUALAN BIOLOGICAL ENGINEERING Medical Blood Products Product Portfolio
7.4.5 HUALAN BIOLOGICAL ENGINEERING Recent Developments
7.5 China Resources Boya Bio-pharmaceutical Group
7.5.1 China Resources Boya Bio-pharmaceutical Group Comapny Information
7.5.2 China Resources Boya Bio-pharmaceutical Group Business Overview
7.5.3 China Resources Boya Bio-pharmaceutical Group Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 China Resources Boya Bio-pharmaceutical Group Medical Blood Products Product Portfolio
7.5.5 China Resources Boya Bio-pharmaceutical Group Recent Developments
7.6 Takeda
7.6.1 Takeda Comapny Information
7.6.2 Takeda Business Overview
7.6.3 Takeda Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Takeda Medical Blood Products Product Portfolio
7.6.5 Takeda Recent Developments
7.7 Octapharma
7.7.1 Octapharma Comapny Information
7.7.2 Octapharma Business Overview
7.7.3 Octapharma Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Octapharma Medical Blood Products Product Portfolio
7.7.5 Octapharma Recent Developments
7.8 LFB Group
7.8.1 LFB Group Comapny Information
7.8.2 LFB Group Business Overview
7.8.3 LFB Group Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 LFB Group Medical Blood Products Product Portfolio
7.8.5 LFB Group Recent Developments
7.9 Kedrion
7.9.1 Kedrion Comapny Information
7.9.2 Kedrion Business Overview
7.9.3 Kedrion Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Kedrion Medical Blood Products Product Portfolio
7.9.5 Kedrion Recent Developments
7.10 Grifols
7.10.1 Grifols Comapny Information
7.10.2 Grifols Business Overview
7.10.3 Grifols Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Grifols Medical Blood Products Product Portfolio
7.10.5 Grifols Recent Developments
7.11 CSL
7.11.1 CSL Comapny Information
7.11.2 CSL Business Overview
7.11.3 CSL Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 CSL Medical Blood Products Product Portfolio
7.11.5 CSL Recent Developments
7.12 BPL
7.12.1 BPL Comapny Information
7.12.2 BPL Business Overview
7.12.3 BPL Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 BPL Medical Blood Products Product Portfolio
7.12.5 BPL Recent Developments
7.13 Biotest
7.13.1 Biotest Comapny Information
7.13.2 Biotest Business Overview
7.13.3 Biotest Medical Blood Products Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Biotest Medical Blood Products Product Portfolio
7.13.5 Biotest Recent Developments
8 North America
8.1 North America Medical Blood Products Market Size by Type
8.1.1 North America Medical Blood Products Revenue by Type (2020-2031)
8.1.2 North America Medical Blood Products Sales by Type (2020-2031)
8.1.3 North America Medical Blood Products Price by Type (2020-2031)
8.2 North America Medical Blood Products Market Size by Application
8.2.1 North America Medical Blood Products Revenue by Application (2020-2031)
8.2.2 North America Medical Blood Products Sales by Application (2020-2031)
8.2.3 North America Medical Blood Products Price by Application (2020-2031)
8.3 North America Medical Blood Products Market Size by Country
8.3.1 North America Medical Blood Products Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Medical Blood Products Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Medical Blood Products Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Medical Blood Products Market Size by Type
9.1.1 Europe Medical Blood Products Revenue by Type (2020-2031)
9.1.2 Europe Medical Blood Products Sales by Type (2020-2031)
9.1.3 Europe Medical Blood Products Price by Type (2020-2031)
9.2 Europe Medical Blood Products Market Size by Application
9.2.1 Europe Medical Blood Products Revenue by Application (2020-2031)
9.2.2 Europe Medical Blood Products Sales by Application (2020-2031)
9.2.3 Europe Medical Blood Products Price by Application (2020-2031)
9.3 Europe Medical Blood Products Market Size by Country
9.3.1 Europe Medical Blood Products Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Medical Blood Products Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Medical Blood Products Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Medical Blood Products Market Size by Type
10.1.1 China Medical Blood Products Revenue by Type (2020-2031)
10.1.2 China Medical Blood Products Sales by Type (2020-2031)
10.1.3 China Medical Blood Products Price by Type (2020-2031)
10.2 China Medical Blood Products Market Size by Application
10.2.1 China Medical Blood Products Revenue by Application (2020-2031)
10.2.2 China Medical Blood Products Sales by Application (2020-2031)
10.2.3 China Medical Blood Products Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Medical Blood Products Market Size by Type
11.1.1 Asia Medical Blood Products Revenue by Type (2020-2031)
11.1.2 Asia Medical Blood Products Sales by Type (2020-2031)
11.1.3 Asia Medical Blood Products Price by Type (2020-2031)
11.2 Asia Medical Blood Products Market Size by Application
11.2.1 Asia Medical Blood Products Revenue by Application (2020-2031)
11.2.2 Asia Medical Blood Products Sales by Application (2020-2031)
11.2.3 Asia Medical Blood Products Price by Application (2020-2031)
11.3 Asia Medical Blood Products Market Size by Country
11.3.1 Asia Medical Blood Products Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Medical Blood Products Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Medical Blood Products Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Medical Blood Products Market Size by Type
12.1.1 SAMEA Medical Blood Products Revenue by Type (2020-2031)
12.1.2 SAMEA Medical Blood Products Sales by Type (2020-2031)
12.1.3 SAMEA Medical Blood Products Price by Type (2020-2031)
12.2 SAMEA Medical Blood Products Market Size by Application
12.2.1 SAMEA Medical Blood Products Revenue by Application (2020-2031)
12.2.2 SAMEA Medical Blood Products Sales by Application (2020-2031)
12.2.3 SAMEA Medical Blood Products Price by Application (2020-2031)
12.3 SAMEA Medical Blood Products Market Size by Country
12.3.1 SAMEA Medical Blood Products Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Medical Blood Products Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Medical Blood Products Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Medical Blood Products Value Chain Analysis
13.1.1 Medical Blood Products Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Medical Blood Products Production Mode & Process
13.2 Medical Blood Products Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Medical Blood Products Distributors
13.2.3 Medical Blood Products Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings